ArticleFrontiers in oncology2022

Risk Assessment in Diffuse Large B-Cell Lymphoma by Combining Baseline Metabolic Tumor Volume and Peking Criteria When Evaluating Series

Tingting Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.